Acid Assault: Unmasking the Toll of Laryngopharyngeal Reflux Disease on Vocal Health - A Literature Review.

Indian J Otolaryngol Head Neck Surg

Department of ENT, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth University, Pillaiyarkuppam, Pondicherry, 607402 India.

Published: February 2025

Laryngopharyngeal reflux disease (LPRD) is characterized by the backflow of gastric contents into the laryngopharynx, distinct from gastroesophageal reflux disease (GERD). Prevalence among otolaryngology patients ranges from 4 to 30% and being the major cause for hoarseness of voice. Common symptoms include hoarseness, chronic coughing, globus sensation, throat clearing and endoscopic evaluation reveals signs like posterior commissure hypertrophy and vocal fold edema. Diagnostic tools such as the Reflux Symptom Index (RSI) and Reflux Finding Score (RFS) aid in assessment, with scores > 13 on RSI and > 7 on RFS indicating LPRD. LPRD significantly contributes to voice disorders, necessitating prompt diagnosis and management. Treatment typically involves proton pump inhibitors (PPIs), leading to symptom improvement within 2-3 months. Understanding the distinct nature of LPRD and its diagnostic criteria is crucial for effective management of this condition. Laryngopharyngeal reflux disease (LPRD) and gastroesophageal reflux disease (GERD) have become epidemics. These diseases are considered to be different entities and therefore present with different symptoms. LPRD, an inflammatory condition which is defined as the regurgitation of gastric contents into the laryngopharynx, where it comes in contact with the tissues of the upper aerodigestive tract. Whereas in GERD, the retrograde flow of contents is restricted to the esophagus. Patients who present with hoarseness for a duration of more than 3 months, the prime causative factor observed is LPRD. Idiopathic hoarseness, chronic coughing, globus sensation, clearing of the throat and choking episodes are the most commonly reported symptoms of LPR (Laryngopharyngeal Reflux). Common signs of LPRD include posterior commissure hypertrophy, vocal fold oedema, hyperaemia, and diffuse laryngeal oedema. Several studies have reported that among patients with voice disorders, LPRD is observed to be a prime factor for their voice change. LPRD can be diagnosed by a simple questionnaire such as Koufman Reflux Symptom Index (KRSI) and Reflux Finding Score (RFS) based on diagnostic evaluation of the larynx by video laryngoscopy. The possibility that the patient is having LPRD is high using these scoring system. Proton pump inhibitors (PPI)s are the mainstay of therapy in LPR. Significant improvement in symptoms have been noted in the patients over a course of few months.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11890824PMC
http://dx.doi.org/10.1007/s12070-024-05279-2DOI Listing

Publication Analysis

Top Keywords

reflux disease
20
laryngopharyngeal reflux
16
lprd
11
reflux
10
disease lprd
8
gastric contents
8
contents laryngopharynx
8
gastroesophageal reflux
8
disease gerd
8
hoarseness chronic
8

Similar Publications

Background: Gastroesophageal reflux disease (GORD) is a significant problem after laparoscopic sleeve gastrectomy (SG). This study aimed to assess the long-term effect of SG with an anterior fundoplication on GORD symptoms.

Methods: A single-centre cohort study of all patients who underwent SG with anterior hemifundoplication (SGAF), with a 2:1 SG only comparison group.

View Article and Find Full Text PDF

Acid Assault: Unmasking the Toll of Laryngopharyngeal Reflux Disease on Vocal Health - A Literature Review.

Indian J Otolaryngol Head Neck Surg

February 2025

Department of ENT, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth University, Pillaiyarkuppam, Pondicherry, 607402 India.

Laryngopharyngeal reflux disease (LPRD) is characterized by the backflow of gastric contents into the laryngopharynx, distinct from gastroesophageal reflux disease (GERD). Prevalence among otolaryngology patients ranges from 4 to 30% and being the major cause for hoarseness of voice. Common symptoms include hoarseness, chronic coughing, globus sensation, throat clearing and endoscopic evaluation reveals signs like posterior commissure hypertrophy and vocal fold edema.

View Article and Find Full Text PDF

Comparison of continuous versus on-demand proton pump inhibitor therapy in symptom control of patients with Barrett's esophagus.

J Formos Med Assoc

March 2025

Division of Gastroenterology and Hepatology, Department of Internal Medicine, An Nan Hospital, China Medical University, Tainan, Taiwan. Electronic address:

Background: Whether continuous proton pump inhibitor (PPI) therapy is superior to on-demand therapy for symptom control of Barrett's esophagus patients is unclear. The study aimed to compare the efficacies of the symptom control and the frequency of co-existent erosive esophagitis in patients with Barrett's esophagus by either continuous or on-demand PPI therapy.

Methods: We randomly assigned (1:1) consecutive adult patients with symptomatic Barrett's esophagus to receive on-demand or continuous esomeprazole (40 mg q.

View Article and Find Full Text PDF

The purpose of this study is to describe the prevalence of problematic feeding in the first 6 months of life in infants born preterm, the impact of feeding problems on the family and parent, and explore which factors known at the time of neonatal discharge predict later symptoms of problematic feeding. The study design is a longitudinal, observational study. The sample included 43 infants born at 28.

View Article and Find Full Text PDF

Unveiling the therapeutic effects of traditional Chinese patent medicines: A network meta-analysis on chronic atrophic gastritis.

Medicine (Baltimore)

March 2025

Hunan Provincial Key Laboratory of Traditional Chinese Medicine Diagnostics, Hunan University of Chinese Medicine, Changsha, Hunan Province, China.

Background: The study aimed to conduct a network meta-analysis of randomized controlled trials (RCTs) to examine the effectiveness and safety of traditional Chinese patent medicine (TCPM), either used alone or combined with conventional treatment (CT) of chemical drugs, for treating chronic atrophic gastritis (CAG).

Methods: We searched the literature from database creation to December 2023; our primary endpoint was clinical response rate. Secondary outcome measures were the inhibition rate of Helicobacter pylori and clinical symptom score, including pain and noisy scores for the stomach, score for belch and acid reflux, score for the bitter taste and the dry throat, and safety according to total adverse events.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!